219 related articles for article (PubMed ID: 21183214)
1. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.
Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Montero-Menei C; Menei P
Biomaterials; 2011 Mar; 32(8):2106-16. PubMed ID: 21183214
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors.
Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Sindji L; Schiller P; Montero-Menei C; Menei P
Biomaterials; 2010 Nov; 31(32):8393-401. PubMed ID: 20688391
[TBL] [Abstract][Full Text] [Related]
3. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
[TBL] [Abstract][Full Text] [Related]
4. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
[TBL] [Abstract][Full Text] [Related]
5. Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?
Auffinger B; Morshed R; Tobias A; Cheng Y; Ahmed AU; Lesniak MS
Oncotarget; 2013 Mar; 4(3):378-96. PubMed ID: 23594406
[TBL] [Abstract][Full Text] [Related]
6. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.
Estella-Hermoso de Mendoza A; Préat V; Mollinedo F; Blanco-Prieto MJ
J Control Release; 2011 Dec; 156(3):421-6. PubMed ID: 21821074
[TBL] [Abstract][Full Text] [Related]
8. Stem cells as vehicles for the treatment of brain cancer.
Mapara KY; Stevenson CB; Thompson RC; Ehtesham M
Neurosurg Clin N Am; 2007 Jan; 18(1):71-80, ix. PubMed ID: 17244555
[TBL] [Abstract][Full Text] [Related]
9. [Local chemotherapy of malignant glioma: from syringe injections to nanotechnology].
Petit S; Garcion E; Benoit JP; Menei P
Rev Neurol (Paris); 2008; 164(6-7):547-53. PubMed ID: 18565353
[TBL] [Abstract][Full Text] [Related]
10. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
[TBL] [Abstract][Full Text] [Related]
11. Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges.
Brioschi AM; Calderoni S; Zara GP; Priano L; Gasco MR; Mauro A
Prog Brain Res; 2009; 180():193-223. PubMed ID: 20302836
[TBL] [Abstract][Full Text] [Related]
12. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
Emerich DF; Winn SR; Bartus RT
Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
[TBL] [Abstract][Full Text] [Related]
13. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
[TBL] [Abstract][Full Text] [Related]
14. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
[TBL] [Abstract][Full Text] [Related]
15. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles.
Gao H; Qian J; Cao S; Yang Z; Pang Z; Pan S; Fan L; Xi Z; Jiang X; Zhang Q
Biomaterials; 2012 Jul; 33(20):5115-23. PubMed ID: 22484043
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
17. Patented nanomedicines for the treatment of brain tumors.
Caruso G; Raudino G; Caffo M
Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Cırpanlı Y; Allard E; Passirani C; Bilensoy E; Lemaire L; Calış S; Benoit JP
Int J Pharm; 2011 Jan; 403(1-2):201-6. PubMed ID: 20951783
[TBL] [Abstract][Full Text] [Related]
19. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
20. [Glioma treatment strategies using mesenchymal stem cells].
Namba H
Brain Nerve; 2010 Oct; 62(10):1075-82. PubMed ID: 20940507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]